Evidence map›Paper›PMID 33572810›Full record

ArticleNutrients2021

Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity.

Gabriella Sistilli, Veronika Kalendova, Tomas Cajka, Illaria Irodenko, Kristina Bardova, Marina Oseeva, Petr Zacek, Petra Kroupova, Olga Horakova, Karoline Lackner and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Antarctic KrillNutrients · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Gabriella SistilliInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.
Veronika KalendovaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.
Tomas CajkaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0002-9728-3355
Illaria IrodenkoInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.
Kristina BardovaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0002-2297-5066
Marina OseevaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.
Petr ZacekProteomics Core Facility, Faculty of Science, Charles University, Division BIOCEV, Prumyslova 595, 25250 Vestec, Czech Republic.
Petra KroupovaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.
Olga HorakovaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0003-0933-4616
Karoline LacknerInstitute of Pathology, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria.
Amalia GastaldelliCardiometabolic Risk Unit, Institute of Clinical Physiology, National Research Council, Via Moruzzi 1, 56100 Pisa, Italy.ORCID 0000-0003-2594-1651
Ondrej KudaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0001-7034-4536
Jan KopeckyInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0001-8072-2035
Martin RossmeislInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic.ORCID 0000-0001-8534-4002
Czech Academy of Sciences · CZCharles University · CZIstituto di Fisiologia Clinica · ITMedical University of Graz · AT

Funding

Czech Science Foundation 17-11027SH2020 Marie Skłodowska-Curie Actions 722619
6 · The paper itself

Abstract

Preclinical evidence suggests that n-3 fatty acids EPA and DHA (Omega-3) supplemented as phospholipids (PLs) may be more effective than triacylglycerols (TAGs) in reducing hepatic steatosis. To further test the ability of Omega-3 PLs to alleviate liver steatosis, we used a model of exacerbated non-alcoholic fatty liver disease based on high-fat feeding at thermoneutral temperature. Male C57BL/6N mice were fed for 24 weeks a lard-based diet given either alone (LHF) or supplemented with Omega-3 (30 mg/g diet) as PLs (krill oil; ω3PL) or TAGs (Epax 3000TG concentrate; ω3TG), which had a similar total content of EPA and DHA and their ratio. Substantial levels of TAG accumulation (~250 mg/g) but relatively low inflammation/fibrosis levels were achieved in the livers of control LHF mice. Liver steatosis was reduced by >40% in the ω3PL but not ω3TG group, and plasma ALT levels were markedly reduced (by 68%) in ω3PL mice as well. Krill oil administration also improved hepatic insulin sensitivity, and its effects were associated with high plasma adiponectin levels (150% of LHF mice) along with superior bioavailability of EPA, increased content of alkaloids stachydrine and trigonelline, suppression of lipogenic gene expression, and decreased diacylglycerol levels in the liver. This study reveals that in addition to Omega-3 PLs, other constituents of krill oil, such as alkaloids, may contribute to its strong antisteatotic effects in the liver.

Indexed as

Dietary SupplementsAnimal Nutritional Physiological PhenomenaAnimalsDiet, High-FatDisease Models, AnimalEuphausiaceaFish OilsHousing, AnimalInsulin ResistanceLiverMaleMiceMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseObesityPhospholipidsFish OilsPhospholipidsC57BL/6N micehigh-fat dietkrill oilNAFLDobesityomega-3phospholipidsthermoneutral temperature

Identifiers

PMID33572810
PMCPMC7912192
OpenAlexW3128468041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.